Treating diabetic retinopathy (DR) is still a significant challenge for clinicians and remains a leading cause of blindness worldwide. NovaGo Therapeutics is developing a human antibody therapy ...

Background: This study was performed to assess the prevalence of dry eye syndrome and diabetic retinopathy (DR) in type 2 diabetic patients and their contributing factors. Methods: 199 type 2 ...

Patients with diabetic retinopathy need special care while pregnant, according to a speaker at Retina 2025. Irena Tsui, MD, said hormonal, metabolic and vascular changes during pregnancy can lead to ...

The "Diabetic Retinopathy - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The report includes an overview of trial numbers and their average ...

The phase 1 clinical trial is a multicenter, open-label, dose-escalation study to assess drug safety via intravitreal ...

The implementation of AIDRSS offers transformative implications for DR screening in India, particularly in rural and ...

Ip, MD, discusses the available treatments for nonproliferative diabetic retinopathy. Ip said about 50% of responders to an American Society of Retina Specialists survey reported that they were ...